About Ampyra (Prescription Drug)

Ampyra™ is the brand name for dalfampridine, an extended release formulation of 4-aminopyridine or 4-AP. Ampyra, a potassium channel blocker, is indicated as a treatment to improve walking in patients with multiple sclerosis.

Learn more about Ampyra in our Ampyra Community Report.

jhartless's Ampyra History (Ongoing)
Ampyra (dalfampridine)
20 mg Daily Jun 10, 2010 - Last Update

jhartless's Ampyra is for…

  • Walking problems

jhartless's side effects of Ampyra…

  • Chronic constipation Jun 12, 2006
  • Dizziness (vertigo) Jun 10, 2010


Jul 12, 2010

20 mg Daily
  • Effectiveness
    Can’t tell (for Walking problems)
  • Effectiveness
    Can’t tell (for Unsteady gait)
  • Side effects
    Moderate (Chronic constipation, Dizziness (vertigo))
  • Adherence
  • Burden
    Not at all hard to take
Advice & Tips
I had high hopes, but unfortunately so far I haven't been able to see any change at all in unsteady gait or walking speed.
$100-199 monthly